Welcome to Team Genus
Asset Allocation & Portfolio Management Tools for Investors
 
  • Welcome : Guest
  • Icon
 
About Team Genus Post your feedback Client Registration
Your Current Location : Fund Card : Fund Summary
 
Tata India Pharma & HealthCare Fund (G) Direct
[Equity: Sectoral]
Other Options
 
Fund Details
Fund Type Growth Launch Date 04 Dec 2015
Corpus(Cr.) 872.0 Scheme NAV 28.3737
Equity(%) 95.88 52 Week High 29.1367
Debt(%) 4.12 52 Week Low 18.3495
Others(%) 0.0 Exit Load 0.25% for redemption Within 30 days
Minimum Investment - Availability Open
Entry Load - Expense Ratio(%) 0.84
Scheme Benchmark NSE - Nifty Pharma Broader Benchmark NSE - Nifty 50 TRI
 
Scheme Objective
Investment Strategy The scheme seeks long term capital appreciation by investing atleast 80% of it`s net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
 
 
 
 
useful links Reserve Bank of India
 
FUNDS : 360  |  Aditya  |  Axis  |  Bajaj  |  Bandhan  |  Bank  |  Baroda  |  Canara  |  DSP  |  Edelweiss  |  Edelweiss  |  Franklin  |  Groww  |  HDFC  |  Helios  |  HSBC  |  ICICI  |  Invesco  |  ITI  |  JM  |  Kotak  |  LIC  |  Mahindra  |  Mirae  |  Motilal  |  NAVI  |  Nippon  |  NJ  |  Old  |  PGIM  |  PPFAS  |  Quant  |  Quantum  |  Samco  |  SBI  |  Shriram  |  Sundaram  |  Tata  |  Taurus  |  TRUST  |  Union  |  UTI  |  WhiteOak  |  Zerodha  | 
 

Disclaimer: While all efforts have been taken to make this web site as authentic as possible, Team Genus Financial Services Private Limited (www.teamgenus.in) will not be responsible for any loss to any person/entity caused by any short-coming; defect or inaccuracy inadvertently or otherwise crept in the teamgenus.in web site. Mutual Fund Investments are subject to market risks, read all scheme related documents carefully before investing into Mutual Funds. The use of information and services is subject to the terms and conditions governing this website.

Follow Us on
Design & Developed by : InvestWell